Massachusetts Attorney General Approves Caritas Christi Sale

Massachusetts Attorney General Martha Coakley has approved the sale of Boston-based non-profit Caritas Christi Health Care to private equity firm Cerberus Capital Management, saying the system could not continue to survive in its current form, according to a Boston Business Journal report.

Advertisement

The deal is one of a few recent high-profile transactions of non-profit systems by for-profit companies. For-profit companies traditionally have more capital for acquisitions. These deals, however, often require additional regulatory approval since the non-profit status of the entity would transfer to for-profit.

Attorney General Coakley ruled in favor of the deal after a five month review, but will require Cerberus to preserve the jobs and fully fund the pensions of current and former Caritas employees. In addition, Cerberus must commit no less than $400 million to capital improvements over four years as well as commit to keeping open all Caritas facilities for a period of five years, providing certain financial margins are met, according to the report.

The original deal, valued at $830 million, was announced in March.

Read the Boston Business Journal report on Caritas Christi.

Read more coverage on Caritas Christi:

– Boston’s Caritas Christi to Close Two Hospitals if Cerberus Deal Fails

– Competitors of Caritas Christi Seek Strict Rules for the System Following Sale to For-Profit Firm

– Massachusetts Will Hold Hearings on Selling Caritas Christi to For-Profit Group

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.